Commissioner Vassiliou's meeting with the European Vaccine Manufacturers
European Commission - IP/09/677 29/04/2009
Other available languages: none
Brussels, 29 April 2009
They exchanged views on the feasibility and the modalities, both from a technical and a regulatory point of view, to produce vaccines against the novel flu virus within the shortest timeframe possible.
The European Commission will continue to work with the industry, which has committed to helping address this public health crisis and to contribute to the effort to reduce the impact and spread of this novel flu virus.